Grant: CIHR Fellowship
McMaster University
$135,000.00
Direct conversion of human skin fibroblasts to the lymphoid lineages
EF 2011-12
Résumé
T and B cells are a subset of white blood cells, crucial for clearing infections. Human diseases caused by a lack of functional T- and B-cells (lymphoid cells) such as HIV and leukemia require constant monitoring and lack robust curative treatments. Treatments do exist, but are complex to administer, ie lymphoid leukemia (a form of blood cancer) with high incidence of relapse can be induced into remission if chemotherapy is intensified and coupled with hematopoietic stem-progenitor cells (HSPC) transplantation, which differentiate into new T and B cells. Unfortunately, sources of patient-matched HSPCs are scarce and requirement for additional transplants increases after chemotherapy, which destroys healthy HSPCs, limiting the routine use of such approaches. Moreover in lymphoid leukemia, T and B cell function is drastically reduced; thereby individuals cannot fight off infections and the most common cause of death is due to opportunistic infections. Previous approaches based on derivation of lymphoid cells from human embryonic stem cells (hESCs) and pluripotent stem cells (hPSCs) have not shown much success. Moreover, the potential of hPSCs to form tumors further limits these approaches. Therefore, novel approaches to obtain patient-specific T- and B-cells are needed. Previous work from our lab demonstrated that fibroblasts (hFibs) derived from human skin samples could generate mature blood cells by inducing expression of Oct-4, a protein involved in self-renewal of stem cells. In this study, I intend to use the direct conversion approach developed in our lab to generate patient-specific lymphoid cells from hFibs through the use of lymphoid-conducive conditions combined with use of additional Oct members, known to promote lymphoid generation. These studies will result in comprehensive understanding of the mechanistic nature of lymphoid development and will offer the opportunity for obtaining patient specific T and B cells that are not available using other sources.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
242368
Name
Kushwah Rahul
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Direct conversion of human skin fibroblasts to the lymphoid lineages
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
B Cells; Flow Cytometry; Hematopoietic Stem-Progenitor Cells; Lymphoid Development; Notch Signaling; Oct Factors; Primary Human Skin Fibroblasts; Quantitave Real-Time Polymerase Chain Reaction; T Cells
Abstract
T and B cells are a subset of white blood cells, crucial for clearing infections. Human diseases caused by a lack of functional T- and B-cells (lymphoid cells) such as HIV and leukemia require constant monitoring and lack robust curative treatments. Treatments do exist, but are complex to administer, ie lymphoid leukemia (a form of blood cancer) with high incidence of relapse can be induced into remission if chemotherapy is intensified and coupled with hematopoietic stem-progenitor cells (HSPC) transplantation, which differentiate into new T and B cells. Unfortunately, sources of patient-matched HSPCs are scarce and requirement for additional transplants increases after chemotherapy, which destroys healthy HSPCs, limiting the routine use of such approaches. Moreover in lymphoid leukemia, T and B cell function is drastically reduced; thereby individuals cannot fight off infections and the most common cause of death is due to opportunistic infections. Previous approaches based on derivation of lymphoid cells from human embryonic stem cells (hESCs) and pluripotent stem cells (hPSCs) have not shown much success. Moreover, the potential of hPSCs to form tumors further limits these approaches. Therefore, novel approaches to obtain patient-specific T- and B-cells are needed. Previous work from our lab demonstrated that fibroblasts (hFibs) derived from human skin samples could generate mature blood cells by inducing expression of Oct-4, a protein involved in self-renewal of stem cells. In this study, I intend to use the direct conversion approach developed in our lab to generate patient-specific lymphoid cells from hFibs through the use of lymphoid-conducive conditions combined with use of additional Oct members, known to promote lymphoid generation. These studies will result in comprehensive understanding of the mechanistic nature of lymphoid development and will offer the opportunity for obtaining patient specific T and B cells that are not available using other sources.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kushwah, Rahul
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~